StockData
Humacyte, Inc. logo

Humacyte, Inc. (HUMA) income statement

HUMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.50−0.00 (-0.20%)

Close on Nov 18, 2026Market cap $138.90MP/E –Yield –

See a number that looks wrong?